Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of $0.01, versus ($0.09) reported last year. Revenue for the quarter came in at $1.18 million, versus $1.25 million reported last year.

The Estimize consensus was $0.00 and $0 , respectively.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

Earnings